Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|October 29, 2004
Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformationsNicholas W Plummer, Carol J Gallione, Sudha Srinivasan, et al.
Molecular and Cellular Biology|March 27, 2013
MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibitionJon S Zawistowski, Kazuhiro Nakamura, Joel S Parker, et al.
Journal of Biomolecular Screening|May 16, 2008
Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerizationKazuhiro Nakamura, Jon S Zawistowski, Mark A Hughes, et al.
Human Molecular Genetics|July 23, 2005
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesisJon S Zawistowski, Lisa Stalheim, Mark T Uhlik, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|February 9, 2006
Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformationsNicholas W Plummer, Teresa L Squire, Sudha Srinivasan, et al.
Science Advances|September 17, 2021
Massively parallel quantification of phenotypic heterogeneity in single-cell drug responsesBenjamin B Yellen, Jon S Zawistowski, Eric A Czech, et al.
Molecular and Cellular Biology|May 30, 2013
SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signalingNicole Vincent Jordan, Aleix Prat, Amy N Abell, et al.
Cell Reports|March 9, 2017
MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal TransitionRobert J Mobley, Deepthi Raghu, Lauren D Duke, et al.
Journal of the American Heart Association|October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor InhibitionTimothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Molecular Cancer Research : MCR|August 6, 2020
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast CancerDaniel R Goulet, Joseph P Foster, Jon S Zawistowski, et al.
Pageof 3